Exploring the structure-activity relationships of ABCC2 modulators using a screening approach.
Bioorg Med Chem
; 23(13): 3513-25, 2015 Jul 01.
Article
em En
| MEDLINE
| ID: mdl-25935289
ABSTRACT
ABCC2 is a transporter with key influence on liver and kidney pharmacokinetics. In order to explore the structure-activity relationships of compounds that modulate ABCC2, and by doing so gain insights into drug-drug interactions, we screened a library of 432 compounds for modulators of radiolabeled ß-estradiol 17-(ß-d-glucuronide) (EG) and fluorescent 5(6)-carboxy-2',7'-dichlorofluorescein transport (CDCF) in membrane vesicles. Following the primary screen at 80µM, dose-response curves were used to investigate in detail 86 compounds, identifying 16 low µM inhibitors and providing data about the structure-activity relationships in four series containing 19, 24, 10, and eight analogues. Measurements with the CDCF probe were consistently more robust than for the EG probe. Only one compound was clearly probe-selective with a 50-fold difference in the IC50s obtained by the two assays. We built 24 classification models using the SVM and fused-XY Kohonen methods, revealing molecular descriptors related to number of rings, solubility and lipophilicity as important to distinguish inhibitors from inactive compounds. This study is to the best of our knowledge the first to provide details about structure-activity relationships in ABCC2 modulation.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Vesículas Transportadoras
/
Proteínas Associadas à Resistência a Múltiplos Medicamentos
/
Bibliotecas de Moléculas Pequenas
Tipo de estudo:
Diagnostic_studies
/
Screening_studies
Limite:
Animals
Idioma:
En
Ano de publicação:
2015
Tipo de documento:
Article